news New genetic analysis reveals early diagnosis for breast cancerBy Dr Zara Kassam (Drug Target Review)
news Novel immuno-oncology treatment for patients with advanced solid tumoursBy Dr Zara Kassam (Drug Target Review)
news CRISPR-Cas9 repairs genetic mutation in human embryosBy James Adjaye (Institute for Stem Cell Research and Regenerative Medicine), justin Bryans (LifeArc), Steve Bremer (Editor: Drug Target Review)
news Novel perspectives on anti-amyloid treatment for the prevention of Alzheimer’sBy Sarah Wills (Editorial Assistant: Drug Target Review)
news Researchers find new genes link to arthritis in bone marrow lesionsBy Niamh Marriott (Drug Target Review)
news Two new genes linked to Alzheimer’s riskBy Sarah Wills (Editorial Assistant: Drug Target Review)
news DFG approves 7 new research units and a new clinical research unitBy Niamh Marriott (Drug Target Review)
news Largest genome-wide study of lung cancer susceptibility conductedBy Niamh Marriott (Drug Target Review)
article New drug targets identified to defend against chlamydia infections using CRISPR and stem cellsBy Amy Yeung (Wellcome Trust Sanger Institute)
news Extra funding for nanomaterials for cancer immunotherapy researchBy Niamh Marriott (Drug Target Review)
news Discovery improves understanding of cellular ageing and cancer developmentBy Niamh Marriott (Drug Target Review)
Follow: